Profile
David W.
Keiser was the founder who founded Alexion Pharmaceuticals, Inc. in 1992 and served as President & Chief Operating Officer until 2008.
He also held former positions as Director at Selexys Pharmaceuticals Corp., Senior Director-Asia Pacific Operations at G.D.
Searle & Co., Inc. from 1986 to 1992, Area Manager at F.
Hoffmann-La Roche Ltd.
in 1983, and Manager-New Business Opportunities at Mundipharma Medical Co. in 1985.
Mr. Keiser received his undergraduate degree from Gettysburg College.
Former positions of David W. Keiser
Companies | Position | End |
---|---|---|
ALEXION PHARMACEUTICALS, INC. | Founder | 2008-12-30 |
G.D. Searle & Co., Inc.
G.D. Searle & Co., Inc. Chemicals: SpecialtyProcess Industries G.D. Searle & Co., Inc. is a company that produces a diverse range of chemicals and agricultural products. The company is based in St. Louis, MO. G.D. Searle & Co. was acquired by Monsanto Co. /Old/ on January 01, 1985. | Corporate Officer/Principal | 1991-12-31 |
Mundipharma Medical Co.
Mundipharma Medical Co. Pharmaceuticals: MajorHealth Technology Mundipharma Medical Co. develops and markets pharmaceutical products. It focuses on analgesics, antiseptics and oncology preparations and also acts as a licensing company for the Purdue, Mundipharma, and Napp companies. The company was founded in 1957 and is headquartered in Basel, Switzerland. | Corporate Officer/Principal | 1984-12-31 |
F. Hoffmann-La Roche Ltd.
F. Hoffmann-La Roche Ltd. Pharmaceuticals: MajorHealth Technology F. Hoffmann-La Roche Ltd. manufactures pharmaceutical products. It offers pharmaceutical drugs, pharmaceutical instruments, and diagnostics solutions. The company was founded by Fritz Hoffmann-La Roche on October 1, 1896 and is headquartered in Basel, Switzerland. | Corporate Officer/Principal | 1982-12-31 |
Selexys Pharmaceuticals Corp.
Selexys Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology Selexys Pharmaceuticals Corp. operates as a biopharmaceutical company, which focuses on development of therapeutics for the treatment of inflammation, thrombosis and metastasis across a broad range of severe diseases. The firm solutions are used to treat vasoocclusion and thrombosis, such as vasoocclusive pain crisis in sickle cell disease and deep venous thrombosis; chronic inflammatory diseases and formation of atherosclerotic plaques. The company was founded by Richard D. Cummings, Richard Alvarez and Rodger P. McEver in 2002 and is headquartered in Oklahoma, OK. | Director/Board Member | - |
Training of David W. Keiser
Gettysburg College | Undergraduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
Private companies | 5 |
---|---|
Alexion Pharmaceuticals, Inc.
Alexion Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Alexion Pharmaceuticals, Inc. engages in the business of serving patients and families affected by rare diseases and devastating conditions through the discovery, development, and commercialization of life-changing medicines. The firm also focuses on the development of haematology, nephrology, neurology, metabolic disorders, cardiology, and ophthalmology. The company was founded by Joseph A. Madri, David W. Keiser, Stephen P. Squinto, and Leonard Bell in January 1992 and is headquartered in Boston, MA. | Health Technology |
F. Hoffmann-La Roche Ltd.
F. Hoffmann-La Roche Ltd. Pharmaceuticals: MajorHealth Technology F. Hoffmann-La Roche Ltd. manufactures pharmaceutical products. It offers pharmaceutical drugs, pharmaceutical instruments, and diagnostics solutions. The company was founded by Fritz Hoffmann-La Roche on October 1, 1896 and is headquartered in Basel, Switzerland. | Health Technology |
Selexys Pharmaceuticals Corp.
Selexys Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology Selexys Pharmaceuticals Corp. operates as a biopharmaceutical company, which focuses on development of therapeutics for the treatment of inflammation, thrombosis and metastasis across a broad range of severe diseases. The firm solutions are used to treat vasoocclusion and thrombosis, such as vasoocclusive pain crisis in sickle cell disease and deep venous thrombosis; chronic inflammatory diseases and formation of atherosclerotic plaques. The company was founded by Richard D. Cummings, Richard Alvarez and Rodger P. McEver in 2002 and is headquartered in Oklahoma, OK. | Health Technology |
G.D. Searle & Co., Inc.
G.D. Searle & Co., Inc. Chemicals: SpecialtyProcess Industries G.D. Searle & Co., Inc. is a company that produces a diverse range of chemicals and agricultural products. The company is based in St. Louis, MO. G.D. Searle & Co. was acquired by Monsanto Co. /Old/ on January 01, 1985. | Process Industries |
Mundipharma Medical Co.
Mundipharma Medical Co. Pharmaceuticals: MajorHealth Technology Mundipharma Medical Co. develops and markets pharmaceutical products. It focuses on analgesics, antiseptics and oncology preparations and also acts as a licensing company for the Purdue, Mundipharma, and Napp companies. The company was founded in 1957 and is headquartered in Basel, Switzerland. | Health Technology |
- Stock Market
- Insiders
- David W. Keiser